Clinical Research Facility

Hoffman Estates, Illinois 60194

We've found

3 trials

at this facility

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Hoffman Estates, IL

Safety and Efficacy of KPI-121 in Subjects With DED

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Hoffman Estates, IL

Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Hoffman Estates, IL

Use our guide to learn which trials are right for you!